ImmuCell Company Profile (NASDAQ:ICCC)

About ImmuCell (NASDAQ:ICCC)

ImmuCell logoImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle, and is developing product line extensions of its existing products that address mastitis. The Company's lead product, First Defense, is manufactured from cows' colostrum utilizing its vaccine and milk protein purification technologies. Its Wipe Out Dairy Wipes are made from a non-woven fabric that allows for a vigorous cleaning. It also developed California Mastitis Test (CMT), which is used for bulk tank, as well as individual cow sample monitoring and is used to determine which quarter of the udder is mastitic. Its product development initiative is Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:ICCC
  • CUSIP: N/A
  • Web: www.immucell.com
Capitalization:
  • Market Cap: $29.96 million
  • Outstanding Shares: 4,848,000
Average Prices:
  • 50 Day Moving Avg: $5.62
  • 200 Day Moving Avg: $5.71
  • 52 Week Range: $4.76 - $8.24
P/E:
  • Trailing P/E Ratio: 43.22
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $10.1 million
  • Price / Sales: 2.97
  • Book Value: $4.20 per share
  • Price / Book: 1.47
Profitability:
  • EBIDTA: $1.94 million
  • Net Margins: 5.32%
  • Return on Equity: 3.11%
  • Return on Assets: 2.48%
Debt:
  • Debt-to-Equity Ratio: 0.18%
  • Current Ratio: 12.13%
  • Quick Ratio: 10.46%
Misc:
  • Average Volume: 6,006 shs.
  • Beta: 0.81
  • Short Ratio: 7.78
 

Frequently Asked Questions for ImmuCell (NASDAQ:ICCC)

What is ImmuCell's stock symbol?

ImmuCell trades on the NASDAQ under the ticker symbol "ICCC."

How were ImmuCell's earnings last quarter?

ImmuCell Co. (NASDAQ:ICCC) posted its quarterly earnings data on Thursday, May, 11th. The company reported $0.12 EPS for the quarter. The company had revenue of $3.54 million for the quarter. ImmuCell had a return on equity of 3.11% and a net margin of 5.32%. View ImmuCell's Earnings History.

Who are some of ImmuCell's key competitors?

Who are ImmuCell's key executives?

ImmuCell's management team includes the folowing people:

  • David Scott Tomsche, Independent Chairman of the Board
  • Michael F. Brigham, President, Chief Executive Officer, Treasurer, Secretary, Director
  • Bobbi Jo Brockmann, Vice President - Sales and Marketing, Director
  • Elizabeth Luttrell Williams, Vice President - Manufacturing Operations
  • Joseph H. Crabb Ph.D., Director
  • Paul R. Wainman, Director
  • David S. Cunningham, Independent Director
  • Linda Rhodes Ph.D., Independent Director
  • Jonathan E. Rothschild, Independent Director

How do I buy ImmuCell stock?

Shares of ImmuCell can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is ImmuCell's stock price today?

One share of ImmuCell stock can currently be purchased for approximately $6.18.


MarketBeat Community Rating for ImmuCell (NASDAQ ICCC)
Community Ranking:  3.3 out of 5 (  )
Outperform Votes:  6 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  9
MarketBeat's community ratings are surveys of what our community members think about ImmuCell and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for ImmuCell (NASDAQ:ICCC) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for ImmuCell (NASDAQ:ICCC)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for ImmuCell (NASDAQ:ICCC)
Earnings by Quarter for ImmuCell (NASDAQ:ICCC)
Earnings History by Quarter for ImmuCell (NASDAQ:ICCC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/11/2017Q1 2017$0.12$3.54 millionViewN/AView Earnings Details
2/9/2017Q416$0.01$2.70 million$2.20 millionViewListenView Earnings Details
11/10/2016Q316$0.01$1.61 million$1.97 millionViewN/AView Earnings Details
5/11/2016Q1$0.11$2.99 millionViewN/AView Earnings Details
2/10/2016Q315$0.09$2.21 million$2.70 millionViewListenView Earnings Details
11/12/2015Q3$0.11$2.47 millionViewListenView Earnings Details
8/13/2015Q215$0.03$1.54 million$1.96 millionViewN/AView Earnings Details
2/11/2015Q414$0.04$1.56 million$2.21 millionViewN/AView Earnings Details
8/12/2014Q214($0.10)$1.37 million$1.54 millionViewN/AView Earnings Details
2/13/2014Q413($0.05)$1.42 million$1.56 millionViewN/AView Earnings Details
11/12/2013Q313$0.02$1.08 million$1.24 millionViewN/AView Earnings Details
11/7/2012Q312($0.02)$1.00 million$1.08 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ImmuCell (NASDAQ:ICCC)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for ImmuCell (NASDAQ:ICCC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for ImmuCell (NASDAQ:ICCC)
Insider Ownership Percentage: 23.20%
Institutional Ownership Percentage: 14.60%
Insider Trades by Quarter for ImmuCell (NASDAQ:ICCC)
Insider Trades by Quarter for ImmuCell (NASDAQ:ICCC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/14/2017David Scott TomscheDirectorBuy2,000$5.43$10,860.00View SEC Filing  
11/7/2016David Scott TomscheDirectorBuy4,000$5.19$20,760.00View SEC Filing  
7/8/2016Joseph H CrabbVPSell1,935$6.55$12,674.25View SEC Filing  
7/7/2016Joseph H CrabbVPSell2,691$6.58$17,706.78View SEC Filing  
7/5/2016Joseph H CrabbVPSell5,374$6.74$36,220.76View SEC Filing  
3/21/2016David Scott TomscheDirectorBuy955$6.67$6,369.85View SEC Filing  
1/29/2016David CunninghamDirectorBuy1,904$5.25$9,996.00View SEC Filing  
9/3/2015Jonathan E. RothschildDirectorBuy3,000$6.63$19,890.00View SEC Filing  
9/1/2015David Scott TomscheDirectorBuy1,000$6.73$6,730.00View SEC Filing  
8/31/2015Jonathan E. RothschildDirectorBuy6,100$7.37$44,957.00View SEC Filing  
8/28/2015David Scott TomscheDirectorBuy1,500$7.27$10,905.00View SEC Filing  
11/26/2014Jonathan E RothschildDirectorBuy2,100$4.82$10,122.00View SEC Filing  
8/20/2014Jonathan E RothschildDirectorBuy3,000$4.55$13,650.00View SEC Filing  
6/16/2014Jonathan E RothschildDirectorBuy5,901$4.57$26,967.57View SEC Filing  
5/15/2014David CunninghamDirectorBuy1,500$3.91$5,865.00View SEC Filing  
8/23/2013Jonathan E RothschildDirectorBuy1,500$3.98$5,970.00View SEC Filing  
8/16/2013David CunninghamDirectorBuy4,000$3.68$14,720.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for ImmuCell (NASDAQ:ICCC)
Latest Headlines for ImmuCell (NASDAQ:ICCC)
Source:
DateHeadline
finance.yahoo.com logoEdited Transcript of ICCC earnings conference call or presentation 11-May-17 8:30pm GMT
finance.yahoo.com - May 12 at 6:32 PM
americanbankingnews.com logoImmuCell Co. (ICCC) Announces Earnings Results
www.americanbankingnews.com - May 12 at 2:46 PM
finance.yahoo.com logoImmuCell Announces Financial Results for First Quarter of 2017
finance.yahoo.com - May 11 at 6:26 PM
finance.yahoo.com logoImmuCell to Announce Financial Results for First Quarter of 2017
finance.yahoo.com - May 4 at 11:35 AM
americanbankingnews.com logoSomewhat Positive Press Coverage Somewhat Likely to Affect ImmuCell (ICCC) Stock Price
www.americanbankingnews.com - April 22 at 2:25 PM
finance.yahoo.com logoImmuCell Corp. :ICCC-US: Earnings Analysis: Q4, 2016 By the Numbers : April 4, 2017
finance.yahoo.com - April 7 at 10:22 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating ImmuCell Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - April 3 at 3:31 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 10-K, Annual Report
biz.yahoo.com - March 30 at 6:12 PM
finance.yahoo.com logoBobbi Jo Brockmann is appointed to Board of Directors of ImmuCell Corporation
finance.yahoo.com - March 8 at 6:36 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Entry into a Material Definitive Ag
biz.yahoo.com - March 8 at 6:36 PM
finance.yahoo.com logoImmuCell Secures $2 Million in Debt Financing
finance.yahoo.com - March 2 at 6:11 PM
finance.yahoo.com logo8:02 am ImmuCell Corporation secures $2 mln in additional bank debt financing
finance.yahoo.com - March 2 at 6:11 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Other Events
biz.yahoo.com - March 2 at 6:11 PM
seekingalpha.com logoImmuCell Corporation (ICCC)
seekingalpha.com - February 11 at 5:53 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition
biz.yahoo.com - February 10 at 6:34 PM
biz.yahoo.com logoQ4 2016 ImmuCell Corp Earnings Release - After Market Close
biz.yahoo.com - February 9 at 6:43 PM
finance.yahoo.com logoImmuCell Announces Preliminary 2016 Financial Results
finance.yahoo.com - February 9 at 6:43 PM
finance.yahoo.com logoImmuCell to Announce Preliminary 2016 Financial Results
finance.yahoo.com - February 6 at 5:54 PM
finance.yahoo.com logoIMMUCELL CORP /DE/ Financials
finance.yahoo.com - November 18 at 5:03 PM
seekingalpha.com logoImmuCell's (ICCC) CEO Michael Brigham on Q3 2016 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 8:02 AM
streetinsider.com logoImmucell Corp (ICCC) Reports Q3 EPS of $0.01
www.streetinsider.com - November 12 at 8:02 AM
finance.yahoo.com logoImmuCell to Announce Third Quarter 2016 Financial Results Conference Call Scheduled for Thursday, November 10, 2016 at 4:30 PM ET
finance.yahoo.com - November 3 at 8:57 AM
finance.yahoo.com logoImmuCell Corporation Announces Closing of $3.5 Million Private Placement of Common Stock
finance.yahoo.com - October 21 at 5:39 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
biz.yahoo.com - October 21 at 5:39 PM
streetinsider.com logoImmucell Corp (ICCC) Offers Prelim. Q3 Results; Says Sales Fell 20%
www.streetinsider.com - October 19 at 10:27 AM
streetinsider.com logoImmuCell Announces Preliminary Third Quarter 2016 Financial Results
www.streetinsider.com - October 18 at 10:37 AM
marketwatch.com logoImmuCell to Raise $3.5 Million in Private Placement
www.marketwatch.com - October 18 at 10:37 AM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement
biz.yahoo.com - October 18 at 10:37 AM
finanznachrichten.de logoImmuCell Announces Second Quarter 2016 Financial Results
www.finanznachrichten.de - August 13 at 8:31 AM
seekingalpha.com logoImmuCell's (ICCC) CEO Michael Brigham on Q2 2016 Results - Earnings Call Transcript
seekingalpha.com - August 13 at 8:31 AM
streetinsider.com logoImmucell Corp (ICCC) Reports Q2 EPS of $0.00
www.streetinsider.com - August 13 at 8:31 AM
biz.yahoo.com logoQ2 2016 ImmuCell Corp Earnings Release - After Market Close
biz.yahoo.com - August 11 at 8:36 AM
finance.yahoo.com logoImmuCell to Announce Second Quarter 2016 Financial Results
finance.yahoo.com - August 3 at 5:52 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders, Financial Statements an
biz.yahoo.com - June 16 at 3:35 PM

Social

Chart

ImmuCell (ICCC) Chart for Sunday, May, 28, 2017

This page was last updated on 5/28/2017 by MarketBeat.com Staff